Great to be back at my alma mater yesterday
@UCSanDiego
Speaking to real estate majors, undergrad
We discussed:
- using AI for day-to-day work
- high interest rate environment impact on deals
- how to land a job in corporate post graduation
Thanks for having me.
Go Tritons!
We are excited to present at #EADV26 Late Breakers the mechanistic and biomarker data for our first-in-class oral treatment for atopic dermatitis and asthma, ENV-294.
ENV-294 targets a previously unengaged pathway, deepens our understanding of the fundamental biology underlying the disease, and presents hope for patients looking for new treatments.
Join us:
Late-Breaker Oral Presentation:
Title: A Previously Undrugged Target in Immune Therapeutics: Oral ENV-294 Provides First Clinical and Molecular Proof of Concept for RAC2 Modulation in Atopic Dermatitis (D3T01.4A)
Presenter: Ester Del Duca, M.D., Ph.D., Laboratory of Inflammatory Skin Diseases, Department of Dermatology, Icahn School of Medicine at Mount Sinai in New York City
Date/Time: Friday, October 2, 2026, 16:00-16:15 CEST / 10:00-10:15 EDT
Room: Hall A, Austria Center Vienna
Oral Presentation:
Title: ENV-294, a First-in-Class Oral Rac2 Modulator, Demonstrates Deep, Durable Efficacy with a Favorable Safety Profile in Moderate-to-Severe Atopic Dermatitis: Results from a Phase 1b Open-Label Study (FC01.1E)
Presenter: Leon Kircik, M.D., Clinical Professor of Dermatology, Icahn School of Medicine at Mount Sinai, New York; Adjunct Clinical Professor of Dermatology, Indiana University School of Medicine
Date/Time: Thursday, October 1, 2026, 09:10-09:20 CEST / 03:10-03:20 EDT
Room: Hall N, Austria Center Vienna
Read more: https://t.co/1wsHEDGyTl
Enveda on the @Nasdaq Tower in @TimesSquareNYC. This special moment was made even better by having our Founder and CEO, @viswacolluru there in person to take it in.
The display marked our $311 million Series E and the years of work behind it: every experiment, every molecule, every late night, every setback that taught us something, and every hard problem solved by our team.
The financing reflects the confidence an exceptional group of investors has placed in Enveda’s platform, pipeline, and long-term ambition. That confidence also carries a responsibility to put the capital to work with discipline and urgency, moving our medicines forward and continuing to turn life’s chemistry into better options for patients.
Thank you to our friends at Nasdaq for marking the moment so beautifull
y.
#Enveda #LearningfromLife #AI #Biotech
I started @enveda so mothers could fight their diagnoses with power mine never had. Sept 18 is her birthday. It’s also the day our first IND cleared, our first patient data came in, and now our Series E closed. More backup for the fight ahead. Happy Birthday, Mom!
Upcoming event in San Diego:
Event: Summer Bash 2026
When: Sept. 23rd from 5:30pm - 8:30pm
Where: 4242 Campus Point Ct, San Diego
Keynote Speaker: @DanMagy , CEO of @Firestorm_Labs
Join 200+ members in the local business community
Hope to see you there!
Details ↓
In the first half of 2026
San Diego has seen an uptick of expansions
Including:
- @zoox
- @Waymo
- @Saronic
- @seasats
- @Firestorm_Labs
E-commerce, aerospace, robotics and maritime has been red-hot.
Biotech on the other hand has been a different story.
Interviewed Kevin back in 2024.
He was scaling his company @epicgardening + running a fast-growing @YouTube channel w/ 2M+ subscribers.
2 years later, he now has 4M+ on YT and collaborating with former US President @BarackObama on gardening content.
You can just do things.
New favorite lunch spot
Queenstown Del Mar 📍
Met w/ an Orange County VC investor who moved to Carlsbad in 2020.
Has made 60+ startup investments to date, 2 which are in local companies in aerospace & tech.
Had the mango shrimp dish 🔥
Highly recommend.
Happening Next Thurs (7/23) in Torrey Pines.
San Diego EDC (@SDRegionalEDC) is recognizing ~100 companies across biotech, tech, consumer, manufacturing who are HQ'd in SD.
In partnership with @Marsh_MMA, @jpmorgan, and others. Be sure to grab your tix.
Hope to see you there!
Meetings at Parakeet Cafe in Del Mar.
Met with Jay Sheth - Director at Jubilant Biosys.
We talked about:
- SD's venture capital x biotech scene
- State of pharma manufacturing in the U.S.
- & much more
Thanks for the time!
New: Harpoon Ventures, San Diego-based VC firm has raised $155M fund.
I’ve been covering Harpoon since its inception. It now has $450M under management.
I wrote about its critical tech strategy, Black Flag accelerator, plus more.
Full piece is now live!